Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:CON NASDAQ:INNV NASDAQ:OPCH NASDAQ:VCYT On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCONConcentra Group Holdings Parent$28.14+3.3%$24.04$18.55▼$28.21$3.49B0.82753,176 shs1.30 million shsINNVInnovAge$9.11-0.4%$7.77$3.13▼$10.69$1.24B0.45286,576 shs359,109 shsOPCHOption Care Health$20.76-0.1%$23.70$18.01▼$36.80$3.26B0.672.96 million shs3.06 million shsVCYTVeracyte$47.33-0.2%$39.43$22.61▼$50.71$3.78B1.981.17 million shs1.08 million shsAnalysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2026 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCONConcentra Group Holdings Parent+3.16%+11.00%+8.92%+25.93%+28.59%INNVInnovAge-0.44%+24.79%+23.27%+8.58%+139.11%OPCHOption Care Health-0.10%+1.22%+4.95%-29.12%-34.49%VCYTVeracyte-0.19%-2.87%+23.74%+47.31%+69.46%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCONConcentra Group Holdings Parent$28.14+3.3%$24.04$18.55▼$28.21$3.49B0.82753,176 shs1.30 million shsINNVInnovAge$9.11-0.4%$7.77$3.13▼$10.69$1.24B0.45286,576 shs359,109 shsOPCHOption Care Health$20.76-0.1%$23.70$18.01▼$36.80$3.26B0.672.96 million shs3.06 million shsVCYTVeracyte$47.33-0.2%$39.43$22.61▼$50.71$3.78B1.981.17 million shs1.08 million shsAnalysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2026 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCONConcentra Group Holdings Parent+3.16%+11.00%+8.92%+25.93%+28.59%INNVInnovAge-0.44%+24.79%+23.27%+8.58%+139.11%OPCHOption Care Health-0.10%+1.22%+4.95%-29.12%-34.49%VCYTVeracyte-0.19%-2.87%+23.74%+47.31%+69.46%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCONConcentra Group Holdings Parent 2.86Moderate Buy$30.207.32% UpsideINNVInnovAge 1.33Sell$7.00-23.16% DownsideOPCHOption Care Health 2.64Moderate Buy$30.5447.10% UpsideVCYTVeracyte 2.56Moderate Buy$47.570.51% UpsideCurrent Analyst Ratings BreakdownLatest INNV, VCYT, CON, and OPCH Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/8/2026OPCHOption Care Health The Goldman Sachs GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy ➝ Neutral$22.006/8/2026OPCHOption Care Health The Goldman Sachs GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageNeutral$22.006/5/2026CONConcentra Group Holdings Parent The Goldman Sachs GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$30.006/2/2026VCYTVeracyte Wolfe ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageOutperform$55.006/1/2026VCYTVeracyte Needham & Company LLCSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$48.00 ➝ $57.006/1/2026VCYTVeracyte Wolfe ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong-Buy5/28/2026VCYTVeracyte Needham & Company LLCSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$48.005/18/2026INNVInnovAge Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold (C-) ➝ Sell (D-)5/11/2026CONConcentra Group Holdings Parent Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold (C+) ➝ Buy (B-)5/11/2026OPCHOption Care Health Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold (C) ➝ Hold (C-)5/11/2026CONConcentra Group Holdings Parent Truist FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$29.00 ➝ $31.00(Data available from 6/13/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCONConcentra Group Holdings Parent$2.16B1.66$2.06 per share13.65$3.13 per share8.99INNVInnovAge$853.70M1.45N/AN/A$1.76 per share5.18OPCHOption Care Health$5.65B0.58$2.04 per share10.17$8.36 per share2.48VCYTVeracyte$517.15M7.30$1.49 per share31.84$16.57 per share2.86Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCONConcentra Group Holdings Parent$166.41M$1.3920.2416.271.247.97%47.14%6.48%8/6/2026 (Estimated)INNVInnovAge-$30.31M-$0.09N/A22.22N/A-1.22%-4.73%-2.20%N/AOPCHOption Care Health$207.59M$1.2916.0911.281.163.64%18.17%7.16%7/29/2026 (Estimated)VCYTVeracyte$66.35M$1.0943.4233.10N/A16.25%9.07%8.38%8/5/2026 (Estimated)Latest INNV, VCYT, CON, and OPCH EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/7/2026Q1 2026CONConcentra Group Holdings Parent$0.35$0.40+$0.05$0.39$553.53 million$569.56 million5/5/2026Q3 2026INNVInnovAge$0.06-$0.22-$0.28-$0.22$234.35 million$251.94 million5/5/2026Q1 2026VCYTVeracyte$0.34$0.52+$0.18$0.35$130.36 million$139.07 million4/30/2026Q1 2026OPCHOption Care Health$0.37$0.40+$0.03$0.29$1.39 billion$1.35 billionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthCONConcentra Group Holdings Parent$0.250.89%N/A17.99%N/AINNVInnovAgeN/AN/AN/AN/AN/AOPCHOption Care HealthN/AN/AN/AN/AN/AVCYTVeracyteN/AN/AN/AN/AN/ALatest INNV, VCYT, CON, and OPCH DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/5/2026CONConcentra Group Holdings Parentquarterly$0.06250.98%5/19/20265/19/20266/9/2026(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCONConcentra Group Holdings Parent3.621.261.26INNVInnovAge0.261.031.03OPCHOption Care Health0.851.641.07VCYTVeracyteN/A9.318.92Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCONConcentra Group Holdings ParentN/AINNVInnovAge12.26%OPCHOption Care Health98.05%VCYTVeracyteN/AInsider OwnershipCompanyInsider OwnershipCONConcentra Group Holdings Parent8.10%INNVInnovAge1.00%OPCHOption Care Health1.70%VCYTVeracyte1.40%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCONConcentra Group Holdings Parent13,133127.96 million117.60 millionN/AINNVInnovAge2,440135.74 million134.38 millionOptionableOPCHOption Care Health8,266157.03 million154.36 millionOptionableVCYTVeracyte79079.79 million78.68 millionOptionableINNV, VCYT, CON, and OPCH HeadlinesRecent News About These CompaniesVeracyte (NASDAQ:VCYT) Hits New 12-Month High - Here's WhyJune 11 at 12:23 PM | marketbeat.comWhy Veracyte (VCYT) is a Top Momentum Stock for the Long-TermJune 11 at 10:52 AM | zacks.comHere's how much a $1000 investment in Veracyte made 10 years ago would be worth todayJune 10 at 7:02 PM | msn.comVeracyte, Inc. $VCYT Shares Sold by GW&K Investment Management LLCJune 10 at 6:53 AM | marketbeat.comVeracyte, Inc. $VCYT Shares Sold by Amova Asset Management Americas Inc.June 10 at 3:08 AM | marketbeat.comHere's Why Veracyte (VCYT) is a Strong Growth StockJune 9, 2026 | zacks.comVeracyte, Inc. (NASDAQ:VCYT) Receives Consensus Rating of "Moderate Buy" from AnalystsJune 8, 2026 | americanbankingnews.comVeracyte, Inc. (NASDAQ:VCYT) Receives Average Rating of "Moderate Buy" from BrokeragesJune 8, 2026 | marketbeat.comBNP Paribas Financial Markets Buys 281,079 Shares of Veracyte, Inc. $VCYTJune 7, 2026 | marketbeat.comMarc Stapley Sells 138,051 Shares of Veracyte (NASDAQ:VCYT) StockJune 6, 2026 | americanbankingnews.comInsider Selling: Veracyte (NASDAQ:VCYT) EVP Sells 3,176 Shares of StockJune 5, 2026 | insidertrades.comVeracyte (NASDAQ:VCYT) EVP Annie Mcguire Sells 3,176 SharesJune 4, 2026 | marketbeat.comVeracyte (NASDAQ:VCYT) CFO Sells $177,088.53 in StockJune 4, 2026 | marketbeat.comVeracyte (NASDAQ:VCYT) Insider John Leite Sells 13,975 SharesJune 4, 2026 | marketbeat.comInsider Selling: Veracyte (NASDAQ:VCYT) CEO Sells 138,051 Shares of StockJune 4, 2026 | marketbeat.comHow Veracyte (VCYT) Investors Can Read The Latest Unchanged Analyst CallJune 4, 2026 | finance.yahoo.comWhy Is Veracyte (VCYT) Up 18.2% Since Last Earnings Report?June 4, 2026 | zacks.comVeracyte, Inc. (VCYT) Discusses ASCO Findings From OPTIMA and ENZAMET Phase III Trials in Breast and Prostate Cancer - SlideshowJune 3, 2026 | seekingalpha.comCanaccord Genuity Reaffirms Their Hold Rating on Veracyte (VCYT)June 3, 2026 | theglobeandmail.comVeracyte, Inc. (VCYT) Presents at 46th Annual William Blair Growth Stock Conference - SlideshowJune 3, 2026 | seekingalpha.comVeracyte (NASDAQ:VCYT) Upgraded to "Strong-Buy" at Wolfe ResearchJune 3, 2026 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesSpaceX Gets the Attention, But These 4 Stocks Could Get the ReturnsBy Bridget Bennett | May 25, 20265 Stocks Winning the AI Race While Everyone Watches NVIDIABy Bridget Bennett | May 26, 2026SpaceX IPO: Opportunity? Or the Ultimate Hype Trade?By Chris Markoch | May 22, 2026Quantum Stocks Just Got a Lifeline—Who Benefits Most?By Nathan Reiff | May 26, 2026After NVIDIA, Broadcom's Earnings Are Next—Here's What to WatchBy Leo Miller | May 26, 2026INNV, VCYT, CON, and OPCH Company DescriptionsConcentra Group Holdings Parent NYSE:CON$28.14 +0.90 (+3.30%) Closing price 06/12/2026 03:59 PM EasternExtended Trading$28.14 +0.00 (+0.00%) As of 06/12/2026 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Concentra Group Holdings Parent, Inc. provides occupational health services in the United States. The company offers occupational and consumer health services, including workers' compensation injury care, urgent care, clinical testing, preventative care, and employer services, as well as wellness programs through occupational health centers and onsite clinics. It also provides Concentra Telemed, a telemedicine solution for the treatment of work-related injuries and illnesses, and employer services; pharmacy solution under the Concentra Pharmacy name; and Concentra Medical Compliance Administration, a third-party administrator that helps to manage abuse testing programs for employers with regulated or non-regulated workforces. The company was founded in 1979 and is based in Mechanicsburg, Pennsylvania. Concentra Group Holdings Parent, Inc. is a subsidiary of Select Medical Corporation.InnovAge NASDAQ:INNV$9.11 -0.04 (-0.44%) Closing price 06/12/2026 04:00 PM EasternExtended Trading$8.90 -0.21 (-2.31%) As of 06/12/2026 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in its homes and communities. The company manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. It also offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management. The company serves participants in the United States; and operates PACE centers in Colorado, California, New Mexico, Pennsylvania, Florida, and Virginia. The company was formerly known as TCO Group Holdings, Inc. and changed its name to InnovAge Holding Corp. in January 2021. InnovAge Holding Corp. was founded in 2007 and is headquartered in Denver, Colorado.Option Care Health NASDAQ:OPCH$20.76 -0.02 (-0.10%) Closing price 06/12/2026 04:00 PM EasternExtended Trading$20.77 +0.01 (+0.05%) As of 06/12/2026 07:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as multiple sclerosis, duchenne muscular dystrophy, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.Veracyte NASDAQ:VCYT$47.33 -0.09 (-0.19%) Closing price 06/12/2026 04:00 PM EasternExtended Trading$47.35 +0.02 (+0.04%) As of 06/12/2026 05:43 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Veracyte, Inc. engages in the research, development and commercialization of diagnostic products. The firm's portfolio includes Afirma, Percepta, and Envisia. It intends to treat thyroid cancer, improve lung cancer screening, and clarify the diagnosis of idiopathic pulmonary fibrosis. The company was founded by Bonnie H. Anderson and Y. Douglas Dolginow on August 15, 2006 and is headquartered in South San Francisco, CA. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas SpaceX Rings the Bell and Shatters Every Record Adobe Stock Just Got Cheaper—Is Wall Street Missing the Story? ERock IPO: A $1.3B Power Play Solution Boeing’s Unseen Rebound: Why the Headlines Are Wrong Why Oracle's 10% Drop May Be Telling the Wrong Story Spotify's "North Star" Outlook Was Music to Investors Ears DraftKings Hits the Jackpot With Super App Pivot Cracker Barrel Surges 23% as Earnings Beat Signals Turnaround Progress Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
